title: [Temporary vena caval filters: report on cohort of 72 patients in Grenoble, France].
abstract: Patients with a contra-indication for anticoagulation can benefit from temporary vena caval filters for protection against pulmonary embolism or recurrence. The filter can be removed secondarily, once the contra-indication is overcome, enabling better long-term outcome by reducing the risk of thrombotic and mechanic complications inherent in these devices. However, it has been shown in several studies that effective withdrawal rates were low and could be improved by the establishment of protocols and registries. We report a retrospective study of withdrawal in 72 patients in whom an ALN® vena caval filter was implanted at the Grenoble University Hospital over a period of three years with an intention for secondary retrieval. Seventy percent of the indications were related to the coexistence of thrombotic and hemorrhagic conditions. Fifty-five percent of filters were removed, the remaining 45% shared involved patients who died before retrieval (11%), those lost to follow-up (4%), technical failure of retrieval (6%), withdrawal technically unfeasible (3%), retrieval refused by patients (6%) and medical indications for continuing filtration (15%). Despite an effective follow-up of these patients and 91% success rate of withdrawal, nearly one out of two filters remains in place. A long-term follow-up of these patients is needed to learn more about the outcome of these filters.
authors.affiliation: Clinique universitaire de médecine vasculaire, CHU de Grenoble, CS 10217, 38043 Grenoble cedex 9, France. Electronic address: cseinturier@chu-grenoble.fr.
authors.forename: C
authors.initials: C
authors.lastname: Seinturier
authors.forename: C
authors.initials: C
authors.lastname: Dornier
authors.forename: F
authors.initials: F
authors.lastname: Thony
authors.forename: S
authors.initials: S
authors.lastname: Blaise
authors.forename: M
authors.initials: M
authors.lastname: Rodière
authors.forename: C
authors.initials: C
authors.lastname: Menez
authors.forename: A-C
authors.initials: AC
authors.lastname: Arnoult
authors.forename: B
authors.initials: B
authors.lastname: Imbert
authors.forename: G
authors.initials: G
authors.lastname: Pernod
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants; D000075202:Contraindications; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000209:etiology / Q000517:prevention & control; D012189:Retrospective Studies; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000150:complications / Q000628:therapy
chemical_list: D000925:Anticoagulants
keywords: Embolie pulmonaire; Filtre cave temporaire; Pulmonary embolism; Registre; Registry; Temporary vena caval filter